Gout Clinical Trials

Find Gout Clinical Trials Near You

Pharmacist-Led Treat-to-Target Urate Lowering Therapy in Patients in Gout (Pharm-UP) Study

Status: Recruiting
Location: See all (5) locations...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study will compare two different approaches to manage medications that lower uric acid levels. This study will be conducted at five VA medical centers across the United States and will take 4-5 years to complete. Individual participation will last up to two years.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• US Veterans with physician-diagnosed

• Documented hyperuricemia (SU \> 6.8 milligrams per deciliter)

• Satisfy American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) gout classification criteria

• Report 1 or more flares in the prior 6 months

• Receipt of a new urate-lowering therapy (ULT) prescription (allopurinol or febuxostat) initiated by a primary care provider or longer term ULT but otherwise satisfy the flare/SU criteria

Locations
United States
Nebraska
Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE
RECRUITING
Omaha
Oregon
VA Portland Health Care System, Portland, OR
RECRUITING
Portland
Pennsylvania
Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA
RECRUITING
Philadelphia
Utah
VA Salt Lake City Health Care System, Salt Lake City, UT
RECRUITING
Salt Lake City
Washington
VA Puget Sound Health Care System Seattle Division, Seattle, WA
RECRUITING
Seattle
Contact Information
Primary
Bridget Kramer
bridget.kramer@va.gov
(402) 995-3206
Time Frame
Start Date: 2026-10-01
Estimated Completion Date: 2031-03-30
Participants
Target number of participants: 310
Treatments
Experimental: Pharmacist-Led
Veterans will participate in regular telehealth visits with study pharmacists. Serum urate lab tests will be ordered during dose escalation phase of gout treatment.
No_intervention: Usual care
Veterans will receive standard care from their primary care provider for the management of their gout.
Related Therapeutic Areas
Sponsors
Leads: VA Office of Research and Development

This content was sourced from clinicaltrials.gov